title: Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.
authors.forename: S G
authors.initials: SG
authors.lastname: Jones
authors.forename: G
authors.initials: G
authors.lastname: Dolan
authors.forename: K
authors.initials: K
authors.lastname: Lengyel
authors.forename: B
authors.initials: B
authors.lastname: Myers
mesh_terms: D000368:Aged; D003404:Creatinine / Q000652:urine*; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced* / Q000652:urine; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000652:urine; D013792:Thalidomide / Q000627:therapeutic use*; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D007166:Immunosuppressive Agents; D013792:Thalidomide; D000077211:Zoledronic Acid; D003404:Creatinine